What clinical variation means to your bottom line: C-level health system executives’ top questions, answered

Wednesday, August 31, 2016 | 1:00pm - 2:00pm CT

Never before has there been a greater imperative to transform healthcare delivery. Healthcare spending continues to accelerate as a percentage of the gross national spend, while the Medicare Access and CHIP Reauthorization Act of 2015, quality incentives and penalties, patient safety indicators and readmissions further pressure hospitals to improve care delivery while eliminating waste. Now Medicare Spending per Beneficiary, part of the IMPACT Act, is resulting in even more change for financially-sensitive providers. Acute care remains at the core of all of these changes, as it is still the leading frontier for cost — making reducing clinical variation critical.

Against this backdrop, as drivers of utilization and solo practice, the role of the physician as a leader and partner in improvement efforts is paramount. Physician leaders play a critical role in cultivating collaboration among all physicians and enabling the hospital administration and physicians to partner together to move strategy forward. Reducing variation successfully and sustainably — while simultaneously maintaining or even improving outcomes — depends upon true partnership between executive leaders and physicians.

In this panel discussion, we will explore various approaches to reducing acute care clinical variation and learn how C-suite leaders can effectively engage their physicians to become part of the solution, ultimately resulting in a positive impact on your own organization’s bottom line.

Attendees will be able to: 

  1. Understand how C-suite executives from four organizations address clinical variation and engage physicians to become part of the solution
  2. Identify and recognize the financial drivers of Medicare Spending per Beneficiary, MACRA and quality incentives, and how these changes are instilling a sense of urgency in addressing clinical variation
  3. Discuss approaches and lessons learned in reducing clinical variation and what this means to financial health and clinical outcomes